Search

Search Constraints

You searched for: Author/Creator Leiter, Lawrence A.

Search Results

21. Design and baseline characteristics of participants in the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial on the cardiovascular effects of dulaglutide. Issue 1 (14th July 2017)

22. Dietary pulses, satiety and food intake: A systematic review and meta‐analysis of acute feeding trials. (13th May 2014)

23. Does management of lipid lowering differ between specialists and primary care: Insights from GOAL Canada. Issue 4 (14th December 2020)

24. Dulaglutide and cardiovascular and heart failure outcomes in patients with and without heart failure: a post‐hoc analysis from the REWIND randomized trial. (20th September 2022)

25. Dulaglutide and incident atrial fibrillation or flutter in patients with type 2 diabetes: A post hoc analysis from the REWIND randomized trial. Issue 4 (24th January 2022)

26. Effect of an siRNA Therapeutic Targeting PCSK9 on Atherogenic Lipoproteins: Prespecified Secondary End Points in ORION 1. Issue 13 (25th September 2018)

27. Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial. Issue 15 (14th April 2020)

28. Effect of Dapagliflozin on Heart Failure and Mortality in Type 2 Diabetes Mellitus. Issue 22 (28th May 2019)

29. Effect of Fructose on Established Lipid Targets: A Systematic Review and Meta‐Analysis of Controlled Feeding Trials. Issue 9 (10th September 2015)

30. Effect of Fructose on Established Lipid Targets: A Systematic Review and Meta‐Analysis of Controlled Feeding Trials. Issue 9 (September 2015)